Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
One World ProductsOWPC Debt-to-EBITDA is 0.22 as of Sep. 2025. The stock has 4 warning signs investors should review. Among 690 Drug Manufacturers companies, One World Products ranks better than 62.03% on this metric.
Debt-to-EBITDA measures a company's ability to pay off its debt.
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
The historical rank and industry rank for One World Products's Debt-to-EBITDA or its related term are showing as below:
OWPC'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: -1.3 Med: -0.41 Max: 0.99
Current: 0.99
During the past 11 years, the highest Debt-to-EBITDA Ratio of One World Products was 0.99. The lowest was -1.30. And the median was -0.41.
OWPC's Debt-to-EBITDA is ranked better than 62.03% of 690
companies
in the Drug Manufacturers industry
Industry Median: 1.64
vs OWPC: 0.99
One World Products (OTCPK:OWPC) Debt-to-EBITDA Explanation
A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.
According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.
One World Products Debt-to-EBITDA Related Terms
One World Products Debt-to-EBITDA Historical Data
* Premium members only.
The historical data trend for One World Products's Debt-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OWPC vs CBSTQ, PTPI, KOAN: Debt-to-EBITDA Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, One World Products's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
One World Products Debt-to-EBITDA vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, One World Products's Debt-to-EBITDA distribution charts can be found below:
* The bar in red indicates where One World Products's Debt-to-EBITDA falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data,
the EBITDA data used here is four times the quarterly (Sep. 2025) EBITDA data.
One World Products (OWPC) has a Debt-to-EBITDA of 0.22 as of Sep. 2025. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on One World Products. According to the industry distribution chart, One World Products ranks #262 out of 690 companies in the Drug Manufacturers industry, placing it in the top 38%.
Is One World Products' Debt-to-EBITDA too high?
One World Products' current Debt-to-EBITDA is 0.22. The Drug Manufacturers industry median Debt-to-EBITDA is 1.64. One World Products' value of 0.22 is 86.6% below this industry median. Based on the distribution chart, One World Products ranks #262 out of 690 companies in the Drug Manufacturers industry, which is above the industry midpoint.
How does One World Products' Debt-to-EBITDA compare to CBSTQ and PTPI?
According to the Drug Manufacturers industry distribution chart, One World Products ranks #262 out of 690 companies for Debt-to-EBITDA. This puts One World Products in the upper half of its industry. The industry median Debt-to-EBITDA is 1.64. One World Products' value of 0.22 is 86.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-EBITDA for a Drug Manufacturers company?
The median Debt-to-EBITDA among Drug Manufacturers companies is 1.64, based on 690 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. One World Products's current Debt-to-EBITDA of 0.22 is 86.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-EBITDA mean?
A high Debt-to-EBITDA can signal that a stock is expensive relative to its fundamentals. Debt-to-EBITDA ratio represents the ratio of total debt to total earnings before interest, taxes, depreciation and amortization. View historical data on One World Products. For the Drug Manufacturers industry, the median Debt-to-EBITDA is 1.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. One World Products's current Debt-to-EBITDA is 0.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is One World Products stock overvalued right now?
One World Products (OWPC) has a current Debt-to-EBITDA of 0.22. The current Debt-to-EBITDA is 0.22 and 86.6% below the Drug Manufacturers industry median of 1.64. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-EBITDA calculated?
Debt-to-EBITDA is calculated from a company's financial statements. For One World Products (OWPC), the current Debt-to-EBITDA is 0.22 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
One World Products Inc along with its subsidiaries is engaged in the cultivation, production, and distribution of raw cannabis and hemp plant ingredients for both medical and industrial uses. It focuses on cultivating, processing, and supplying cannabis oil, distillate, and isolate to customer's specifications. The Company operates as a single segment, consisting of its CBD sales operations in the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OWPC has been successfully added to your 
